CASSIDY GAVIN SANDERS: Open Payments
NPI 1144989500 · EUDORA, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$109 in 6 payments from 6 companies in 2025. Trend: 2023 $68 · 2024 $46 · 2025 $109
Food & beverage: $109
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: RYBREVANT, UBRELVY, Auvelity, CAPLYTA, INGREZZA, REXULTI.
Industry payments across AR — which companies pay providers there.
